Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study.

ABSTRACT:

Objectives

To assess the impact of herpes zoster vaccination in the 5 years after introduction for 70- to 79-year-olds in England in September 2013.

Design

Population based ecological impact assessment.

Setting

Hospitals covering the whole English population for the period 2008 to 2018 and 293 general practices (GP) for the period 2005 to 2018, in England.

Participants

Over the period the population contributed 117·5 million person-years for hospitalisation events and 6.96 million person-years for GP events in individuals aged 60 to 89.

Interventions

Live attenuated herpes zoster vaccination (Zostavax), first used on 1^st September 2013, in 70- and 79-year-olds with continued use in new 70 year-olds and with a staged catch-up of those aged 71 t

SUBMITTER: Andrews N 

PROVIDER: S-EPMC7342826 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature